Full CoverageTop news
Cases remain high in the U.S., but vaccinations are slowing. (Published 2021)
By Andrea Kannapell, Isabella Grullón Paz & Bryan Pietsch
Blood Clots and the Johnson & Johnson Vaccine: What We Know So Far
By Jim Daley
CDC, FDA lift pause on using J&J’s coronavirus vaccine, add safety warning
By Maggie Fox
All coverage
U.S. Lifts Pause In Use Of J&J Vaccine After Vote By Expert Panel
By Laurel Wamsley
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.’s request.
By Sheryl Gay Stolberg
Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
J.&.J. Vaccine Will Be Available Again Soon (Published 2021)
By Denise Grady, Noah Weiland & Julie Bosman
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sheryl Gay Stolberg, Sharon LaFraniere & Chris Hamby
The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again.
By Noah Weiland, Carl Zimmer & Emily Anthes
FDA inspection found problems at factory making J&J vaccine
By Linda A. Johnson